Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 IMMUNOSUPPRESSANTS
L04A IMMUNOSUPPRESSANTS
L04AK Dihydroorotate dehydrogenase (DHODH) inhibitors
L04AK02 Teriflunomide
D10172 Teriflunomide (USAN) <US>
USP drug classification [BR:br08302]
Central Nervous System Agents
Multiple Sclerosis Agents
Teriflunomide
D10172 Teriflunomide (USAN)
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Dehydrogenases
DHODH
D10172 Teriflunomide (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10172
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10172
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10172